Aurinia Pharmaceuticals ( ($AUPH) ) has issued an update. Aurinia Pharmaceuticals reported a significant increase in financial performance for the ...
Aurinia (AUPH) delivered earnings and revenue surprises of +43.75% and +7.31%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Aurinia Pharmaceuticals Inc. AUPH) on Tuesday reported third-quarter earnings of $31.6 million. On a per-share basis, the Edmonton, Alberta-based company said it had profit of 23 cents.
An update from Aurinia Pharmaceuticals ( ($AUPH) ) is now available. Aurinia Pharmaceuticals reported significant financial growth for the third ...
George Tidmarsh, the newly installed director of the FDA’s Center for Drug Evaluation and Research, was placed on leave ...
A lawsuit filed against George Tidmarsh, who resigned from a top FDA post on Sunday, includes a series of incendiary texts ...
Dr. George Tidmarsh, the FDA drug regulator who was placed on leave and complained of a “toxic” work environment in an ...
The drama continued Monday with senior FDA leaders as more details emerged about former Center for Drug Evaluation and ...
Dr. George Tidmarsh, who joined the FDA in July, stepped down Sunday, The New York Times reported. His resignation came just ...
The top drug regulator at the Food and Drug Administration (FDA) resigned Sunday, according to officials, after being accused ...
Observers characterized the dismissals, policy reversals, and controversies at the FDA as a soap opera, total disarray, and potentially, unprincipled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback